PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 387 of 673

Advanced search
馃嚭馃嚫Regulatorysec.govTier 1 路 Regulatory source

Bristol Myers Squibb filed Form 10-Q

SEC EDGAROriginal source
馃嚭馃嚫Regulatorysec.govTier 1 路 Regulatory source

Bristol Myers Squibb filed Form 8-K

SEC EDGAROriginal source
馃嚭馃嚫Regulatorysec.govTier 1 路 Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source
馃嚭馃嚫Regulatorysec.govTier 1 路 Regulatory source

Sanofi filed Form 6-K

SEC EDGAROriginal source
馃嚫馃嚞Researchscri.edu.sgTier 2 路 Direct publisher

Singapore Clinical Trials Symposium Brings Together Clinical Research Community

Singapore Clinical Research InstituteOriginal source
馃嚳馃嚘Researchnews.uct.ac.zaTier 2 路 Direct publisher

From discovery to impact: UCT showcase reimagines the postdoctoral journey

University of Cape TownOriginal source
馃嚭馃嚢Researchnature.comTier 2 路 Direct publisher

Effects of CYP3A4, CYP3A5 , and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation

The Pharmacogenomics JournalOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Medicare Program; Updates to the Master List of Items Potentially Subject to Face-to-Face Encounter and Written Order Prior to Delivery and/or Prior Authorization Requirements; Updates to the Required Face-to-Face Encounter and Written Order Prior to Delivery List; and Updates to the Required Prior

This document announces updates to the Healthcare Common Procedure Coding System (HCPCS) codes on th...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Butylated Hydroxytoluene (BHT); Request for Information; Reopening of Comment Period

The Food and Drug Administration (FDA or we) is reopening the comment period for the notice titled "...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Office of the Director, National Institutes of Health; Notice of Meeting

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Office of the Secretary; Amended Notice of Meeting

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Health Center Program Forms-OMB No. 0915-0285-Revision

In compliance with the requirement for opportunity for public comment on proposed data collection pr...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Announcement of the Intent To Award Single-Source Grants (Multiple Recipients) for Necessary Expenses Directly Related to the Consequences of Hurricanes Fiona and Ian

ACF/OHS announces its intent to award multiple single-source grants totaling $143,436,162 to select...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Administrative Costs for Children in Title IV-E Foster Care

This document withdraws a proposed rule that was published in the Federal Register on January 31, 20...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Biosimilar User Fee Rates for Fiscal Year 2027

The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for biosimilar user fe...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Food Safety Modernization Act Voluntary Qualified Importer Program User Fee Rate for Fiscal Year 2027

The Food and Drug Administration (FDA or we) is announcing the fiscal year (FY) 2027 annual fee rate...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Over-the-Counter Monograph Drug User Fee Rates for Fiscal Year 2027

The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Over-the-Counter Monograph Dr...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Generic Drug User Fee Rates for Fiscal Year 2027

The Federal Food, Drug, and Cosmetic Act (FD&C Act or statute), as amended by the Generic Drug User...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Outsourcing Facility Fee Rates for Fiscal Year 2027

The Food and Drug Administration (FDA or we) is announcing the fiscal year (FY) 2027 rates for the e...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2027

The Food and Drug Administration (FDA, the Agency, or we) is announcing the fee rates and payment pr...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Animal Drug User Fee Rates and Payment Procedures for Fiscal Year 2027

The Food and Drug Administration (FDA, the Agency, or we) is announcing the fee rates and payment pr...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Food Safety Modernization Act Third-Party Certification Program User Fee Rate for Fiscal Year 2027

The Food and Drug Administration (FDA or we) is announcing the fiscal year (FY) 2027 annual fee rate...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Food Safety Modernization Act Domestic and Foreign Facility Reinspection, Recall, and Importer Reinspection Fee Rates for Fiscal Year 2027

The Food and Drug Administration (FDA or we) is announcing the fiscal year (FY) 2027 fee rates for c...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Medical Device User Fee Rates for Fiscal Year 2027

The Food and Drug Administration (FDA, Agency, or we) is announcing the fee rates and payment proced...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Prescription Drug User Fee Rates for Fiscal Year 2027

The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for prescription drug...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Office of the Director, National Institutes of Health; Amended Notice of Meeting

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Joan Rubinger, N.P.; Decision and Order

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

Agency Information Collection Activities: Proposed Collection; Comment Request

This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to requ...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryfederalregister.govTier 1 路 Regulatory source

National Center for Health Statistics, Meeting of the ICD-10 Coordination and Maintenance Committee

The Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS),...

Federal RegisterOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Cefpodoxime Proxetil

Official structured record identifier: 8519a9d8-7106-4545-bc58-859ee9a6708e.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Icy Hot Performance No-Mess Pain Relief Cream

Official structured record identifier: 5e3e272a-c001-4f57-9535-521ccc85ae65.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: SPIRONOLACTONE

Official structured record identifier: 57d1c333-c229-54aa-e063-6394a90a84ce.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Clevariel Minoxidil Hair Growth Serum

Official structured record identifier: 57cfd24c-19ab-b9bb-e063-6394a90aa835.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: QUZYTTIR

Official structured record identifier: 573770f6-b76e-f6ba-e063-6294a90aa54d.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: prednisone

Official structured record identifier: 5218e88b-468b-4d60-ab7e-78cca632b23a.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: KinderFarms Childrens Pain and Fever

Official structured record identifier: 4f86419a-b940-a9c6-e063-6394a90a6a2b.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: OTTFFSS SMELLING SALTS

Official structured record identifier: 4e76504b-82da-e7a4-e063-6294a90a4f81.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Vonjo

Official structured record identifier: 4b5ab444-0e1a-4984-99db-76ad11a298ee.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Pain Relief Acetaminophen 325 mg

Official structured record identifier: 49a59b79-b8b4-4bf5-a403-0a14751efc55.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Ozempic

Official structured record identifier: 42bdd912-2393-44c4-b7e0-47672ca28991.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Metformin Hydrochloride

Official structured record identifier: 41408f64-d366-403e-9595-464ab25c6f97.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: FLUEndz

Official structured record identifier: 3ddf6b45-6794-43a6-828d-cc53ae809994.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: FENOFIBRATE

Official structured record identifier: 3b6c5ebd-a8bc-4502-8b66-f4e58914815b.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Lamotrigine

Official structured record identifier: 35aa48a2-2ce6-4a6e-bf5a-1bc6111d1234.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Benzonatate

Official structured record identifier: 23a5de40-76d0-4117-8d31-2b2f8a6b0a28.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Azithromycin Dihydrate

Official structured record identifier: 21c67de0-3a4e-caab-e063-6394a90ae3cd.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Valsartan

Official structured record identifier: 1a8af3d9-4053-4233-82a7-e8c7bc9e302f.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Ustekinumab-aekn

Official structured record identifier: 183a1dff-ef33-4ddb-ba38-f7861b0f77ad.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: unspecified product

Official structured record identifier: 176b400b-2b4e-481d-b6c4-0f99e4c711c3.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Phenylephrine Hydrochloride

Official structured record identifier: 1767c4b7-36a0-4e64-9091-2af22161402f.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Valsartan and Hydrochlorothiazide

Official structured record identifier: 167f49f0-2d39-49a2-9f9e-1359a7c7ba3d.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Hypertonic Saline

Official structured record identifier: 167c7a9c-1228-4fb2-a89c-d3e148386323.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Pancreaforce

Official structured record identifier: 0e067fba-762b-4897-8a2b-75d9b77242e3.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Pravastatin Sodium

Official structured record identifier: 0c4b59f1-92a8-44f8-8b4c-691f35777460.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Muscle Ice

Official structured record identifier: 03b6e2a9-f335-4ae2-9011-80bd019afb72.

openFDA Drug LabelsOriginal source
馃嚭馃嚫Regulatoryopen.fda.govTier 1 路 Regulatory source

Drug label update: Aspercreme with Lidocaine Dry

Official structured record identifier: 008abaaa-5e12-4246-a7f5-66f3966acf28.

openFDA Drug LabelsOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan

PR NewswireOriginal source
馃嚜馃嚭Researcheuropepmc.orgTier 2 路 Direct publisher

Molecular Restoration Through Replacement Therapies: Current Advances and Future Directions in Treating Diseases.

Europe PMCOriginal source
馃嚜馃嚭Researcheuropepmc.orgTier 2 路 Direct publisher

Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial.

Europe PMCOriginal source